Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda | Zendy

Jacqueline E. Tate | Zendy; Fidèle Ngabo | Zendy; Philippe Donnen | Zendy; Maurice Gatera | Zendy; Jeannine Uwimana | Zendy; Celse Rugambwa | Zendy; Jason M. Mwenda | Zendy; Umesh D. Parashar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda

Author(s) -

Jacqueline E. Tate,

Fidèle Ngabo,

Philippe Donnen,

Maurice Gatera,

Jeannine Uwimana,

Celse Rugambwa,

Jason M. Mwenda,

Umesh D. Parashar

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ1016

Subject(s) - rotavirus vaccine , medicine , rotavirus , odds ratio , confidence interval , vaccination , pediatrics , diarrhea , immunization , virology , immunology , antigen

Rotavirus vaccine efficacy is lower in low-income countries than in high-income countries. Rwanda was one of the first low-income countries in sub-Saharan Africa to introduce rotavirus vaccine into its national immunization program. We sought to evaluate rotavirus vaccine effectiveness (VE) in this setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research